Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-27 Purchase(A) |
2025-03-10 4:11 pm |
BioAge Labs Inc. | BIOA | Hemrajani Rekha Director |
3,000 | $18 | $54,000 | 3,000 (Direct) |
View |
| 2024-12-02 Purchase |
2024-12-04 4:17 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
30,000 | $1.5468 | $46,404 | 33,000 (Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:03 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
3,000 | $19 | $57,000 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-21 Option Award |
2025-01-23 6:32 pm |
N/A 2035-01-20 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
40,400 | $0 | 40,400 (Direct) |
View |
| 2024-09-25 Option Award |
2024-09-27 4:21 pm |
N/A 2034-09-24 |
BioAge Labs Inc. | BIOA | Hemrajani Rekha Director |
43,497 | $0 | 43,497 (Direct) |
View |
Ownership |
2024-09-25 4:54 pm |
N/A 2031-12-15 |
BioAge Labs Inc. | BIOA | Hemrajani Rekha Director |
0 | $0 | 63,669 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:49 pm |
N/A 2034-06-12 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
20,200 | $0 | 20,200 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 5:38 pm |
N/A 2034-06-10 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
62,068 | $0 | 62,068 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:31 pm |
N/A 2033-06-21 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 4:43 pm |
N/A 2033-06-19 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
20,200 | $0 | 20,200 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-21 4:45 pm |
N/A 2033-03-19 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-08 4:03 pm |
N/A 2032-06-28 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
26,900 | $0 | 26,900 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 8:23 pm |
N/A 2032-06-14 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:15 pm |
N/A 2031-08-09 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2021-07-29 6:37 pm |
N/A 2031-06-14 |
MAXCYTE INC. | MXCT | Hemrajani Rekha Director |
0 | $0 | 80,700 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:50 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
12,004 | $0 | 12,004 (Direct) |
View |
Ownership |
2020-11-18 8:10 pm |
N/A N/A |
Jiya Acquisition Corp. | JYAC | Hemrajani Rekha Chief Executive Officer |
0 | $0 | 200,000 (Direct) |
View |
Ownership |
2020-07-16 6:37 pm |
N/A 2030-04-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
0 | $0 | 87,378 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-25 5:45 pm |
N/A 2030-06-22 |
Adverum Biotechnologies Inc. | ADVM | Hemrajani Rekha Director |
30,000 | $0 | 30,000 (Direct) |
View |